thyssenkrupp nucera Partners with OxyChem to Install Next Generation eBiTAC v7 Electrolyzers
EQS-Media / 24.05.2023 / 10:23 CET/CEST
thyssenkrupp nucera Partners with OxyChem to Install Next Generation eBiTAC v7 Electrolyzers
- thyssenkrupp nucera next generation eBiTAC v7 electrolyzers will be installed at OxyChem's Battleground large-scale chlor-alkali electrolysis plant in LaPorte, Texas.
- OxyChem's Battleground plant, the largest chlorine and caustic soda producer, is converting to membrane technology.
La Porte/Dortmund, May 24, 2023 – thyssenkrupp nucera is partnering with OxyChem to install the latest generation eBiTAC v7 electrolyzers to support the conversion of its Battleground plant in LaPorte, Texas, from the diaphragm to membrane chlor-alkali technology.
"The fact that OxyChem has contracted us for the important retrofit of its large chlor-alkali plant makes us very pleased because it demonstrates the great trust and partnership, we have built with OxyChem through our chlor-alkali technology and service," says Dr. Werner Ponikwar, CEO and Chairman of the Executive Board of thyssenkrupp nucera AG & Co. KGaA.
thyssenkrupp nucera offers world-class technologies for highly efficient electrolysis plants and supports the conversion of OxyChem's Battleground plant diaphragm cells. Production and delivery will take approximately three years, and thyssenkrupp nucera will expand its manufacturing facilities to accommodate this significant supply agreement.
"OxyChem has had a long-standing partnership with thyssenkrupp nucera that supports our production of essential commodity chemicals helping elevate the quality of life across the globe”, says Wade Alleman, OxyChem Executive Vice President of Technology, Business Development & Support. "This multi-year project will modernize our chlor-alkali manufacturing process and increase our production capacity.”
In this project, thyssenkrupp nucera was involved in the early stages of project development and supplied the basic design for the core of the chlor-alkali facility. The transformation of the chlor-alkali plant into membrane technology is scheduled to begin in 2023 and is expected to be finished by 2026.
Media inquiries:
Investor inquiries:
About thyssenkrupp nucera:
thyssenkrupp nucera offers world-leading technologies for highly efficient electrolysis plants. The company has extensive expertise in the design, procurement, and construction of electrochemical plants. Its track record includes more than 600 successfully installed projects with a total capacity of more than 10 gigawatts. thyssenkrupp nucera's chlor-alkali electrolysis plants allow significant savings in construction costs and offer fast, simple, and cost-effective assembly.
www.thyssenkrupp-nucera.com
End of Media Release
Issuer: thyssenkrupp nucera AG & Co. KGaA
Key word(s): Enterprise
24.05.2023 CET/CEST Dissemination of a Press Release, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com
|
Language: |
English |
Company: |
thyssenkrupp nucera AG & Co. KGaA |
| Voßkuhle 38 |
| 44141 Dortmund |
| Germany |
E-mail: |
info@thyssenkrupp.com |
Internet: |
www.thyssenkrupp-nucera.com |
ISIN: |
DE000NCA0001 |
WKN: |
NCA000 |
Listed: |
Regulated Market in Frankfurt |
EQS News ID: |
1640615 |
IPO geplant / Intended to be listed; |
1640615 24.05.2023 CET/CEST
Die wichtigsten Finanzdaten auf einen Blick
|
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
Umsatzerlöse1 |
0,00 |
0,00 |
0,00 |
254,25 |
319,50 |
383,19 |
652,80 |
EBITDA1,2 |
0,00 |
0,00 |
0,00 |
30,04 |
30,05 |
12,22 |
28,70 |
EBITDA-Marge3 |
0,00 |
0,00 |
0,00 |
11,82 |
9,41 |
3,19 |
|
EBIT1,4 |
0,00 |
0,00 |
0,00 |
26,75 |
26,90 |
8,82 |
23,80 |
EBIT-Marge5 |
0,00 |
0,00 |
0,00 |
10,52 |
8,42 |
2,30 |
3,65 |
Jahresüberschuss1 |
0,00 |
0,00 |
0,00 |
21,67 |
21,29 |
6,04 |
22,50 |
Netto-Marge6 |
0,00 |
0,00 |
0,00 |
8,52 |
6,66 |
1,58 |
3,45 |
Cashflow1,7 |
0,00 |
0,00 |
0,00 |
4,28 |
36,60 |
87,11 |
-14,20 |
Ergebnis je Aktie8 |
0,00 |
0,00 |
0,00 |
0,17 |
0,17 |
0,06 |
0,23 |
Dividende8 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
Quelle: boersengefluester.de und Firmenangaben
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: KPMG
|
INVESTOR-INFORMATIONEN |
©boersengefluester.de |
ThyssenKrupp Nucera |
WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
NCA000 |
10,680 |
|
1.349,04 |
KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
267,00 |
0,00 |
0,00 |
84,09 |
KBV |
KCV |
KUV |
EV/EBITDA |
1,79 |
- |
1,57 |
-84,76 |
Dividende '22 in € |
Dividende '23 in € |
Div.-Rendite '23 in % |
Hauptversammlung |
0,00 |
0,00 |
0,00 |
05.02.2025 |
Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
13.02.2025 |
15.05.2025 |
14.08.2025 |
17.12.2024 |
Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
14,60% |
5,88% |
0,75% |
-34,48% |
|
|